Growth Capital • Manufacturing

DevCo Partners Invests In Vexve

On June 30, 2016, private equity firm DevCo Partners invested in manufacturer Vexve

Investment Context

This is DevCo Partners’ 1st transaction in the Manufacturing sector.
This is DevCo Partners’ 1st transaction in Finland.

Explore All 383 Growth Capital Manufacturing Deals - Search the Database Free

Investment Summary
Date	June 30, 2016
Target	Vexve
Sector	Manufacturing
Investor(s)	DevCo Partners
Deal Type	Growth Capital

Target Company

Vexve

Sastamala, Finland

Vexve is a manufacturer of valves for district heating applications for heating and cooling applications (HVAC/R) as well as Oil and Gas piping systems. Developed for demanding applications, Vexve valve and control products, and hydraulic control solutions are used in district energy networks, power plants, and internal heating and cooling systems of buildings. Vexve was founded in 1960 and is based in Sastamala, Finland.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Investor Overview 1

Investor

DevCo Partners

Investor Investor

Category	Private Equity Firm
Founded	2014
Size	Small
Type	Sector Agnostic

DESCRIPTION

DevCo Partners is a Finnish private investment firm focused on growth-oriented investments in middle-market Nordic companies. The Firm has no sector preferences and pursues companies with considerable growth and international potential, and revenues of €50 to €500 million. DevCo Partners was formed in 2014 and is based in Helsinki.

Deal Context for Investor	#
Overall	1 of 3
Sector: Manufacturing	1 of 1
Type: Growth Capital	1 of 2
Country: Finland	1 of 3
Year: 2016	1 of 1

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2018-02-01	Medix Biochemica Espoo, Finland Medix Biochemica develops, manufactures, and markets critical raw materials including antibodies, antigens, and biologicals for IVD companies worldwide. Medix Biochemica was founded in 1985 and is based in Espoo, Finland.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2018-02-01

Medix Biochemica

Espoo, Finland

Medix Biochemica develops, manufactures, and markets critical raw materials including antibodies, antigens, and biologicals for IVD companies worldwide. Medix Biochemica was founded in 1985 and is based in Espoo, Finland.

Buy

Explore Related M&A Activity

Manufacturing M&A - Growth Capital M&A Deals - Finland M&A - 2016 M&A